A Population Pharmacokinetic/Pharmacodynamic Analysis of Regadenoson, an Adenosine A 2A -Receptor Agonist, in Healthy Male Volunteers

By Gordi Toufigh  

Clinical Pharmacokinetics, Vol. 45, Iss. 12, 2006-01 ,pp. : 1201-1212

Adis International

Access to resources Recommend Favorite

PARP activity in peripheral blood lymphocytes as a predictive biomarker for PARP inhibition in tumor tissues – A population pharmacokinetic/pharmacodynamic analysis of rucaparib

By  

Clinical Pharmacology In Drug Development, Vol. 4, Iss. 2, 2015-03 ,pp. : 89-98

John Wiley & Sons Inc

Access to resources Recommend Favorite

Fexofenadine: biochemical, pharmacokinetic and pharmacodynamic properties and its unique role in allergic disorders

By Smith Steven M   Gums John G  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 7, 2009-07 ,pp. : 813-822

Informa Healthcare

Access to resources Recommend Favorite

Mixture Modeling for the Detection of Subpopulations in a Pharmacokinetic/Pharmacodynamic analysis

By Lemenuel-diot Annabelle   Laveille Christian   Frey Nicolas   Jochemsen Roeline   Mallet Alain  

Journal of Pharmacokinetics and Pharmacodynamics, Vol. 34, Iss. 2, 2007-04 ,pp. : 157-181

Springer Publishing Company

Access to resources Recommend Favorite

Population pharmacokinetic analysis of mirtazapine

By Grasmäder Katja   Verwohlt Petra   Kühn Kai-Uwe   Dragicevic Aleksandra   Widdern Olrik   Zobel Astrid   Hiemke Christoph   Rietschel Marcella   Maier Wolfgang   Jaehde Ulrich   Rao Marie  

European Journal of Clinical Pharmacology, Vol. 60, Iss. 7, 2004-09 ,pp. : 473-480

Springer Publishing Company

Access to resources Recommend Favorite